MeSH D059352 - musculoskeletal pain
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Duloxetine | Duloxetine | 2013-12-11 | |||
| Mylan | Duloxetine | Duloxetine Mylan | 2015-06-19 | |||
| Lupin Research | Duloxetine | Duloxetine | 2013-12-11 | |||
| Boehringer Ingelheim | Duloxetine | Duloxetine Boehringer Ingelheim | 2008-10-08 | |||
| Eli Lilly | Duloxetine | Ariclaim | 2004-08-11 | |||
| Duloxetine | Cymbalta | 2004-08-03 | $283.3 M | Y2022 | ||
| Duloxetine | Duloxetine Lilly | 2014-12-08 | ||||
| Duloxetine | Yentreve | 2004-08-11 | ||||
| Aurobindo Pharma | Duloxetine | Duloxetine | 2013-12-11 | |||
| Ajanta Pharma | Duloxetine | Duloxetine | 2017-01-06 | |||
| Zydus Therapeutics | Duloxetine | Duloxetine | 2014-01-08 | |||
| Sun Pharmaceutical Industries | Duloxetine | Drizalma | 2037-04-13 | 2019-07-19 | ||
| Duloxetine | Duloxetine | 2013-12-11 | ||||
| Alembic Pharmaceuticals | Duloxetine | Duloxetine | 2014-06-09 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
71%5/7
Phase 2
50%12/24
Phase 3
28%5/18
Approved: 2Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use